CVS Drug Pricing Overhaul Signals a Broader Industry Shift

CVS Health’s new plan to make the way it prices prescription drugs more predictable is the latest shift by pharmacy giants to overhaul their business models amid increasing pressure from policymakers and industry upstarts. It’s possible CVS was starting to see the advantages of its secretive pricing model erode, “especially as Congress is set to act on rebates,” former FDA commissioner Scott Gottlieb wrote on X, formerly Twitter.

Read the full article: CVS Drug Pricing Overhaul Signals a Broader Industry Shift //

Source: https://www.axios.com/2023/12/06/cvs-drug-pricing-overhaul

Scroll to Top